Evidence map›Paper›PMID 29866424›Full record

ReviewAnaerobe2018

Expansion of the Clostridium perfringens toxin-based typing scheme.

Julian I Rood, Vicki Adams, Jake Lacey, Dena Lyras, Bruce A McClane, Stephen B Melville, Robert J Moore, Michel R Popoff, Mahfuzur R Sarker, J Glenn Songer and 2 more

Open access · bronzeAbstract readReview
In one paragraph

Review in Anaerobe, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 322 papers.

0numbers the graph read from it
0cells of the map it votes in
322citing papers in PubMed
31.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

322 citing papers in PubMed, 589 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Suboptimal PAM Enables One-Pot RPA-CRISPR/Cas12a Detection ofCurrent issues in molecular biology · 2026
    Article
  6. Isolation, Genomic Evolution, and Pathogenicity ofAnimals : an open access journal from MDPI · 2026
    Article
  7. Article
  8. Epidemiological and Metabolic Characteristics ofAnimals : an open access journal from MDPI · 2026
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

262 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 9 institutions in 4 countries.

Julian I RoodInfection and Immunity Program, Monash Biomedicine Discovery Institute and Department of Microbiology, Monash University, Clayton, Victoria 3800, Australia. Electronic address: julian.rood@monash.edu.
Vicki AdamsInfection and Immunity Program, Monash Biomedicine Discovery Institute and Department of Microbiology, Monash University, Clayton, Victoria 3800, Australia.
Jake LaceyInfection and Immunity Program, Monash Biomedicine Discovery Institute and Department of Microbiology, Monash University, Clayton, Victoria 3800, Australia; CSIRO Biosecurity Flagship, Australian Animal Health Laboratory, Geelong, Victoria 3220, Australia.
Dena LyrasInfection and Immunity Program, Monash Biomedicine Discovery Institute and Department of Microbiology, Monash University, Clayton, Victoria 3800, Australia.
Bruce A McClaneDepartment of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Stephen B MelvilleDepartment of Biological Sciences, Virginia Tech, Blacksburg, VA, USA.
Robert J MooreInfection and Immunity Program, Monash Biomedicine Discovery Institute and Department of Microbiology, Monash University, Clayton, Victoria 3800, Australia; School of Science, RMIT University, Bundoora, Victoria 3083, Australia.
Michel R PopoffUnité Des Bactéries Anaérobies et Toxines, Institut Pasteur, 25 Rue Du Dr Roux, 75724, Paris Cedex 15, France.
Mahfuzur R SarkerDepartment of Biomedical Sciences, College of Veterinary Medicine, Oregon State University, Corvallis, OR 97331, USA.
J Glenn Songer
Francisco A UzalCalifornia Animal Health and Food Safety Laboratory, San Bernardino Branch, School of Veterinary Medicine, University of California-Davis, San Bernardino, CA 92408, USA.
Filip Van ImmerseelDepartment of Pathology, Bacteriology and Avian Diseases, Faculty of Veterinary Medicine, Ghent University, Merelbeke, Belgium.
Monash University · AUCalifornia State University, San Bernardino · USCommonwealth Scientific and Industrial Research Organisation · AUGhent University · BEInstitut Pasteur · FROregon State University · USUniversity of Arizona · USUniversity of Pittsburgh · USVirginia Tech · US

Funding

MECHANISMS OF ACTION OF C PERFRINGENS EXTEROTOXINR01AI019844 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI MC CLANE, BRUCE A · 1985 to 2024
$5.4M
Mechanisms of Action of C. Perfringens EnterotoxinR37AI019844 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI MC CLANE, BRUCE A · 2005 to 2014
$3.0M
Characterization of a Type II secretion system in a Gram-positive pathogenR21AI109391 · NIAID · VIRGINIA POLYTECHNIC INST AND ST UNIV · PI MELVILLE, STEPHEN · 2014 to 2015
$413k
Pathogenic Contributions of Clostridium perfringens NanI SialidaseR21AI125796 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI LI, JIHONG, MC CLANE, BRUCE A · 2016 to 2017
$402k
NIAID NIH HHS R01 AI019844NIAID NIH HHS R21 AI109391NIAID NIH HHS R21 AI125796NIAID NIH HHS R37 AI019844
6 · The paper itself

Abstract

Clostridium perfringens causes many different histotoxic and enterotoxic diseases in humans and animals as a result of its ability to produce potent protein toxins, many of which are extracellular. The current scheme for the classification of isolates was finalized in the 1960s and is based on their ability to produce a combination of four typing toxins - α-toxin, β-toxin, ε-toxin and ι-toxin - to divide C. perfringens strains into toxinotypes A to E. However, this scheme is now outdated since it does not take into account the discovery of other toxins that have been shown to be required for specific C. perfringens-mediated diseases. We present a long overdue revision of this toxinotyping scheme. The principles for the expansion of the typing system are described, as is a mechanism by which new toxinotypes can be proposed and subsequently approved. Based on these criteria two new toxinotypes have been established. C. perfringens type F consists of isolates that produce C. perfringens enterotoxin (CPE), but not β-toxin, ε-toxin or ι-toxin. Type F strains will include strains responsible for C. perfringens-mediated human food poisoning and antibiotic associated diarrhea. C. perfringens type G comprises isolates that produce NetB toxin and thereby cause necrotic enteritis in chickens. There are at least two candidates for future C. perfringens toxinotypes, but further experimental work is required before these toxinotypes can formally be proposed and accepted.

Indexed as

AnimalsBacterial ToxinsBacterial Typing TechniquesClostridium InfectionsClostridium perfringensHumansBacterial ToxinsClostridium perfringensDiseasePathogenesisTerminologyToxinotypingToxins

Identifiers

PMID29866424
PMCPMC6195859
OpenAlexW2800937934

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.